Oncology

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on key innovations in veterinary oncology

Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session

Lovey presented to the clinic lethargic, with inappetence but consuming plenty of water, and a bulge on her abdomen when lying down

The type of lesion will guide treatment and prognosis

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

AI Masses is an addition to Zoetis’ Vetscan Imagyst platform

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.

Jörg Mayer, DVM, MS, DABVP, DECZM, DACZM, discusses how bee venom and honey benefits veterinary oncology, in a dvm360 interview

Managing maximum tolerated dose (MTD) chemotherapy while minimizing neutropenia relies on precise complete blood count (CBC) monitoring and AI-powered diagnostics.

Over the next 3 years, IDEXX Cancer Dx will expand to include most canine cancer cases

Integrative therapies can enhance a patient’s survival and quality of life

Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about Laverdia-CA1, as well as indolent lymphoma in this interview with dvm360

Craig A Clifford, DVM, MS, DACVIM (Oncology), talks about the general practitioner’s role in the care for patients with cancer

Craig A Clifford, DVM, MS, DACVIM (Oncology), talks about mast cell tumors, sharing a bit about cytological grading, treatment options, common misconceptions, and more

Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about the most common bladder tumor in dogs, misdiagnosis, and the Cadet BRAF test assay

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights.

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), discusses some of the latest advances in veterinary oncology

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), discusses his lecture “Mast Cell Tumors: The Latest and Greatest,” in an interview with dvm360

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), talks about his lecture “Lymphoma – What’s New?”, presented at the Fetch dvm360 conference in Atlantic City, New Jersey

Canalevia-CA1 is currently the only treatment on the market for treating CID in canine patients.

Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York

Sue Ettinger, DVM, DACVIM (Oncology), discusses the importance of cancer awareness with Adam Christman, DVM, MBA, in recognition of National Pet Cancer Awareness Month

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Calviri recently announced the initiation of new vaccine trial that targets early-stage hemangiosarcoma tumors in canines

The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the most common feline diseases